M G Netea

Author PubWeight™ 62.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2005 1.64
2 The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2007 1.58
3 Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2004 1.54
4 Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999 1.49
5 The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis. Neth J Med 2007 1.40
6 Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 2005 1.35
7 Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 2011 1.32
8 Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis 2008 1.30
9 Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis 2008 1.28
10 Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2. Atherosclerosis 2010 1.26
11 An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000 1.23
12 Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 2001 1.12
13 Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology 2012 1.11
14 Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice. FEMS Immunol Med Microbiol 1999 1.03
15 Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001 1.02
16 Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur Cytokine Netw 2002 1.02
17 Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol 1999 1.02
18 Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest 2000 1.01
19 LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors. Atherosclerosis 1998 1.00
20 Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis. J Immunol Methods 1999 0.98
21 Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes (Lond) 2008 0.96
22 Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol 2003 0.96
23 Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology 2011 0.95
24 Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B. J Antimicrob Chemother 1998 0.95
25 The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998 0.93
26 Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens. Infect Immun 2001 0.93
27 A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria. Parasite Immunol 2007 0.92
28 Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases. Scand J Immunol 2005 0.92
29 Anakinra for the inflammatory complications of chronic granulomatous disease. Neth J Med 2011 0.90
30 A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever. Clin Microbiol Infect 2013 0.89
31 High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Rom J Physiol 2000 0.89
32 Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice. J Infect Dis 1998 0.88
33 Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect Immun 2012 0.88
34 Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections. J Infect Dis 1998 0.87
35 Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol 2009 0.87
36 The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers. Immunology 1997 0.86
37 The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance. Diabetes Obes Metab 2014 0.86
38 Circulating galectin-3 in infections and non-infectious inflammatory diseases. Eur J Clin Microbiol Infect Dis 2013 0.86
39 Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes. Cytokine 2000 0.85
40 Autophagy is redundant for the host defense against systemic Candida albicans infections. Eur J Clin Microbiol Infect Dis 2013 0.85
41 Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. Neth J Med 2006 0.85
42 Critical aneurysmal dilatation of the thoracic aorta in young adolescents with variant hyperimmunoglobulin E syndrome. J Intern Med 2006 0.84
43 Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis. Clin Microbiol Infect 2011 0.84
44 Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin Exp Immunol 2009 0.84
45 Association of autophagy-related 16-like 1 (ATG16L1) gene polymorphism with sepsis severity in patients with sepsis and ventilator-associated pneumonia. Eur J Clin Microbiol Infect Dis 2014 0.81
46 Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth J Med 2003 0.81
47 Oxidation of low-density lipoproteins by acellular components of Chlamydia pneumoniae. J Infect Dis 2000 0.81
48 Combined treatment: antifungal drugs with antibodies, cytokines or drugs. Med Mycol 2000 0.80
49 The impact of caspase-12 on susceptibility to candidemia. Eur J Clin Microbiol Infect Dis 2011 0.80
50 Hypothesis: Normalisation of cytokine dysbalance explains the favourable effects of strict glucose regulation in the critically ill. Neth J Med 2004 0.80
51 Molecular view on PRR cross-talk in antifungal immunity. Cell Microbiol 2012 0.80
52 Leptin and proinflammatory cytokines in patients undergoing peritoneal dialysis. Eur J Clin Invest 2003 0.80
53 Polymorphisms in cytokine genes IL6, TNF, IL10, IL17A and IFNG influence susceptibility to complicated skin and skin structure infections. Eur J Clin Microbiol Infect Dis 2014 0.79
54 Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-alpha, but does not affect IL-1beta, IL-6, or IL-10. Cytokine 2003 0.78
55 Invasive fungal infection in an elderly patient with defective inflammatory macrophage function. Clin Microbiol Infect 2011 0.78
56 Mycoviruses: future therapeutic agents of invasive fungal infections in humans? Eur J Clin Microbiol Infect Dis 2010 0.78
57 Modulation of LPS-, PHA- and M. tuberculosis-mediated cytokine production by pentoxifylline and thalidomide. Eur Cytokine Netw 2000 0.77
58 Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. Clin Exp Allergy 2015 0.77
59 Side effects of anticytokine strategies. Neth J Med 2005 0.77
60 Modulation of muramyl dipeptide stimulation of cytokine production by blood components. Clin Exp Immunol 2009 0.77
61 Proinflammatory cytokines and treatment of disease. Ann N Y Acad Sci 1998 0.76
62 Immunomodulation by n-3 polyunsaturated fatty acids. Immunol Today 1999 0.76
63 Pathogenesis of fever: are circulating pyrogenic cytokines the only mediators? Clin Infect Dis 1998 0.75
64 The effect of salicylates on insulin sensitivity. J Clin Invest 2001 0.75
65 Modulation of the pro- and antiinflammatory cytokines by amphotericin B. J Infect Dis 1999 0.75
66 LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia. Atherosclerosis 1998 0.75
67 Integrin mediated adhesion of mononuclear cells from patients with familial hypercholesterolemia. Eur J Clin Invest 1999 0.75
68 Lipoprotein (a) concentrations in patients with familial combined hyperlipidemia and hypertension. Neth J Med 1999 0.75
69 [Cytokines and immunotherapy in infectious diseases]. Ned Tijdschr Geneeskd 1999 0.75
70 Serum lipoprotein(a) is increased in hypertensive NIDDM patients. Diabetes Care 1995 0.75
71 Increased soluble interleukin-2 receptor concentrations in patients with insulin-dependent diabetes mellitus. Diabet Med 1997 0.75
72 Pulmonary infection, and not systemic inflammation, accounts for increased concentrations of exhaled nitric oxide in patients with septic shock. J Breath Res 2013 0.75